Role of fecal calprotectin as a hypoxic intestinal damage biomarker in COVID-19 patients

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–13.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Adriana DN, Miftahussurur M. Current strategy to combat COVID-19 in Indonesia. New Armen Med J. 2020;14:16–28.

Google Scholar 

Sungnak W, Huang N, Bécavin C, Berg M, Queen R, Litvinukova M, et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26:681–7.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Wan Y, Li J, Shen L, Zou Y, Hou L, Zhu L, et al. Enteric involvement in hospitalized patients with COVID-19 outside Wuhan. Lancet Gastroenterol Hepatol. 2020;5:534–5.

PubMed  PubMed Central  Article  Google Scholar 

Zeng F, Huang Y, Guo Y, Yin M, Chen X, Xiao L, et al. Association of inflammatory markers with the severity of COVID-19: a meta-analysis. Int J Infect Dis. 2020;96:467–74.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420–2.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–33.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Gu Y, Wang D, Chen C, Lu W, Liu H, Lv T, et al. PaO2 /FiO2 and IL-6 are risk factors of mortality for intensive care COVID-19 patients. Sci Rep. 2021;11:7334.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J, et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol. 2020;115:766–73.

PubMed  Article  Google Scholar 

Jin X, Lian JS, Hu JH, Gao J, Zheng L, Zhang YM, et al. Epidemiological, clinical, and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020;69:1002–9.

CAS  PubMed  Article  Google Scholar 

Dahiya DS, Kichloo A, Albosta M, Pagad S, Wani F. Gastrointestinal implications in COVID-19. J Investig Med. 2020;68:1397–401.

PubMed  Article  Google Scholar 

Kopel J, Perisetti A, Gajendran M, Boregowda U, Goyal H. Clinical insights into the gastrointestinal manifestations of COVID-19. Dig Dis Sci. 2020;65:1932–9.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Beeching NJ, Fletcher TE, Fowler R. BMJ best practice coronavirus disease 2019 (COVID-19). London: BMJ Publishing Group Ltd; 2021. p. 1–364.

Google Scholar 

Guo M, Tao W, Flavell RA, Zhu S. Potential intestinal infection and faecal–oral transmission of SARS-CoV-2. Nat Rev Gastroenterol Hepatol. 2021;18:269–83.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Scaldaferri F, Ianiro G, Privitera G, Lopetuso LR, Vetrone LM, Petito V, et al. The thrilling journey of sars-cov-2 into the intestine: From pathogenesis to future clinical implications. Inflamm Bowel Dis. 2020;26:1306–14.

PubMed  Article  Google Scholar 

Cheung KS, Hung IFN, Chan PPY, Lung KC, Tso E, Liu R, et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: Systematic review and meta-analysis. Gastroenterology. 2020;159:81–95.

CAS  PubMed  Article  Google Scholar 

Trottein F, Sokol H. Potential causes and consequences of gastrointestinal disorders during a SARS-CoV-2 infection. Cell Rep. 2020;32: 107915.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Jena A, Kumar-M P, Singh AK, Sharma V. Fecal calprotectin levels in COVID-19: lessons from a systematic review on its use in inflammatory bowel disease during the pandemic. Dig Liver Dis. 2021;53:295–7.

CAS  PubMed  Article  Google Scholar 

Mitsuyama K, Tsuruta K, Takedatsu H, Yoshioka S, Morita M, Niwa M, et al. Clinical features and pathogenic mechanisms of gastrointestinal injury in COVID-19. J Clin Med. 2020;9:3630.

CAS  PubMed Central  Article  Google Scholar 

Zhang H, Kang Z, Gong H, Xu D, Wang J, Li Z, et al. Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process. Gut. 2020;69:1010–8.

CAS  Article  Google Scholar 

Ye Q, Wang B, Zhang T, Xu J, Shang S. The mechanism and treatment of gastrointestinal symptoms in patients with COVID-19. Am J Physiol-Gastroint Liver Physiol. 2020;319:245–52.

Article  CAS  Google Scholar 

Ma C, Cong Y, Zhang H. COVID-19 and the digestive system. Am J Gastroenterol. 2020;115:1003–6.

PubMed  Article  Google Scholar 

Giuffrè M, di Bella S, Sambataro G, Zerbato V, Cavallaro M, Occhipinti AA, et al. COVID-19-induced thrombosis in patients without gastrointestinal symptoms and elevated fecal calprotectin: hypothesis regarding mechanism of intestinal damage associated with COVID-19. Trop Med Infect Dis. 2020;5:1–5.

Google Scholar 

Yao Y, Cao J, Wang Q, Shi Q, Liu K, Luo Z, et al. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: A case control study. J Intensive Care. 2020;8:49.

PubMed  PubMed Central  Article  Google Scholar 

Acheson DWK, Luccioli S. Microbial-gut interactions in health and disease. Mucosal immune responses. Best Pract Res Clin Gastroenterol. 2004;8:387–404.

Article  CAS  Google Scholar 

Mago S, Vaziri H, Tadros M. The usefulness of fecal calprotectin in the era of the COVID-19 pandemic. Gastroenterology. 2021;160:2622–3.

Article  CAS  Google Scholar 

Burri E, Beglinger C. The use of fecal calprotectin as a biomarker in gastrointestinal disease. Expert Rev Gastroenterol Hepatol. 2014;8:197–210.

CAS  PubMed  Article  Google Scholar 

Bjarnason I. The use of fecal calprotectin in inflammatory bowel disease. Gastroenterol Hepatol. 2017;13:53–6.

Google Scholar 

Giuffrè M, Vetrugno L, di Bella S, Moretti R, Berretti D, Crocè LS. Calprotectin and SARS-CoV-2: a brief-report of the current literature. Healthcare (Switzerland). 2021;9:956.

Google Scholar 

Tahir M, Arshid S, Fontes B, Castro MS, Luz IS, Botelho KLR, et al. Analysis of the effect of intestinal ischemia and reperfusion on the rat neutrophils proteome. Front Mol Biosci. 2018;5:1–15.

Article  CAS  Google Scholar 

Britton GJ, Chen-Liaw A, Cossarini F, Livanos AE, Spindler MP, Plitt T, et al. Limited intestinal inflammation despite diarrhea, fecal viral RNA, and SARS-CoV-2-specific IgA in patients with acute COVID-19. Sci Rep. 2021;11:13308.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Zerbato V, di Bella S, Giuffre M, Jaracz AW, Gobbo Y, Luppino D, et al. High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: a proof-of-concept study. World J Gastroenterol. 2021;27:3130–7.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Effenberger M, Grabherr F, Mayr L, Schwaerzler J, Nairz M, Seifert M, et al. Faecal calprotectin indicates intestinal inflammation in COVID-19. Gut. 2020;69:1543–4.

CAS  PubMed  Article  Google Scholar 

Ojetti V, Saviano A, Covino M, Acampora N, Troiani E, Franceschi F, et al. COVID-19 and intestinal inflammation: role of fecal calprotectin. Dig Liver Dis. 2020;52:1231–3.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Shokri-Afra H, Alikhani A, Moradipoodeh B, Noorbakhsh F, Fakheri H, Moradi-Sardareh H. Elevated fecal and serum calprotectin in COVID-19 are not consistent with gastrointestinal symptoms. Sci Rep. 2021;11:22001.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Udeh R, Advani S, García L, Romualdo G, Dolja-Gore X. Calprotectin, an emerging biomarker of interest in COVID-19: a systematic review and meta-analysis. J Clin Med. 2021;10:775.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Burhan E, Dwi Susanto A, Isbaniah F, Aman Nasution S, Ginanjar E, Wicaksono Pitoyo C, et al. Pedoman Tatalaksana COVID-19 Edisi 3 Perhimpunan Dokter Paru Indonesia (PDPI) Perhimpunan Dokter Spesialis Kardiovaskular Indonesia (PERKI) Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia (PAPDI) Perhimpunan Dokter Anestesiologi dan Terapi Intensif. 2020.

Sartini S, Massobrio L, Cutuli O, Campodonico P, Bernini C, Sartini M, et al. Role of SatO2, PaO2/FiO2 ratio and PaO2 to predict adverse outcome in COVID-19: a retrospective, cohort study. Int J Environ Res Public Health. 2021;18:11534.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Rice TW, Wheeler AP, Bernard GR, Hayden DL, Schoenfeld DA, Ware LB. Comparison of the SpO2/FIO2 ratio and the PaO2/FIO2 ratio in patients with acute lung injury or ARDS. Chest J. 2007;132:410–7.

Article  Google Scholar 

Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA J Am Med Assoc. 2012;307:2526–33.

Google Scholar 

Colgan SP, Campbell EL, Kominsky DJ. Hypoxia and mucosal inflammation. Annu Rev Pathol. 2016;11:77–100.

CAS 

留言 (0)

沒有登入
gif